Clinical Trial Update: Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating low dose upper abdominal radiation therapy with gemcitabine in advanced, unresectable pancreatic cancer; study completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Neoplasms
• Ovarian Neoplasms
• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• LD-UART (Low Dose Upper Abdominal Radiation Therapy)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Gastrointestinal Neoplasms, Ovarian Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-04-09